Nina Gulbrandsen

A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony‐stimulating factor: significant effects on quality of life

Eva Hellström‐Lindberg, Nina Gulbrandsen, Greger Lindberg et al. · British Journal of Haematology · 2003 · 454 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

Anders Waage, Peter Gimsing, Peter Fayers et al. · Blood · 2010 · 231 citations · Full text

Medicine, Hematology, Oncology +13

UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M‐proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)

Jenny Bird, Judith Behrens, Jan Westin et al. · British Journal of Haematology · 2009 · 137 citations

Medicine, Hematology, Oncology +10

Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences

Nina Gulbrandsen, Marianne Jensen Hjermstad, Finn Wislöff · European Journal Of Haematology · 2004 · 124 citations

Medicine, Oncology, Chemotherapy +14

Health-Related Quality of Life in Multiple Myeloma Patients Receiving High-Dose Chemotherapy with Autologous Blood Stem-Cell Support

Nina Gulbrandsen, Lorentz Brinch, Kristina Carlson et al. · Medical Oncology · 2001 · 84 citations

Medicine, Hematology, Oncology +17